JSKN027

· Jiangsu Alphamab Biopharmaceuticals Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for JSKN027, covering 2026-02-06 to 2026-02-06. Get the full timeline:

Most recent: Clinical Trial Update: A Study of JSKN027 in Patients With Advanced Solid Tumors [Phase 1]